| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/21/2011 | CA2470731C Corticotropin releasing factor 2 receptor agonists |
| 06/21/2011 | CA2465641C Phenoxy amine compounds and compositions for delivering active agents |
| 06/21/2011 | CA2430934C A method of producing sustained-release preparations of a bioactive substance using high-pressure gas |
| 06/21/2011 | CA2427088C Interferon-beta purification and recovery |
| 06/21/2011 | CA2407556C Gene detection assay for improving the likelihood of an effective response to an erbb antagonist cancer therapy |
| 06/21/2011 | CA2405547C Protective agent against reinfection after liver transplantation |
| 06/21/2011 | CA2396796C Stabilized medicinal aerosol particulate formulations |
| 06/21/2011 | CA2396785C A medicinal aerosol formulation |
| 06/21/2011 | CA2396648C A medicinal aerosol formulation |
| 06/21/2011 | CA2386019C Methods related to immunostimulatory nucleic acid-induced interferon |
| 06/21/2011 | CA2376381C Server-assisted regeneration of a strong secret from a weak secret |
| 06/21/2011 | CA2370775C Use of a serenoa repens extract for the production of a medicament to treat prostate cancer |
| 06/21/2011 | CA2359115C Acyl derivatives which treat vla-4 related disorders |
| 06/21/2011 | CA2355347C Pharmaceutical compositions comprising quinapril magnesium |
| 06/21/2011 | CA2342770C Ly6h gene |
| 06/21/2011 | CA2340328C Stable hypoxia inducible factor-1 alpha and method of use |
| 06/21/2011 | CA2323071C Molecules that home to various selected organs or tissues |
| 06/21/2011 | CA2303460C Synergistic effects of op/bmp morphogens and gdnf/ngf neurotrophic factors |
| 06/21/2011 | CA2299442C Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions |
| 06/21/2011 | CA2297408C Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof |
| 06/21/2011 | CA2288222C Oligonucleotide mediated specific cytokine induction and in vivo protection from infection |
| 06/21/2011 | CA2280791C Immunological detection of prions |
| 06/21/2011 | CA2202873C Process for purification of factor viii |
| 06/21/2011 | CA2172392C Methods of inhibiting phagocytosis |
| 06/21/2011 | CA2171336C Recombinant il4 antibodies useful in treatment of il4 mediated disorders |
| 06/16/2011 | WO2011072288A2 Insulin analogues with chlorinated amino acids |
| 06/16/2011 | WO2011072266A2 Aminoacyl trna synthetases for modulating hematopoiesis |
| 06/16/2011 | WO2011072265A1 Aminoacyl trna synthetases for modulating inflammation |
| 06/16/2011 | WO2011072247A2 Pathogen restriction factors |
| 06/16/2011 | WO2011072216A2 Treatment methods utilizing stem cell mobilizers and immunosuppressive agents |
| 06/16/2011 | WO2011072138A2 Therapeutic use of protein-polymer conjugates |
| 06/16/2011 | WO2011072115A1 Ldl quantitation and methods of use |
| 06/16/2011 | WO2011072059A1 Use of transferrin in treatment of beta-thalassemias |
| 06/16/2011 | WO2011071992A1 Inhibition of tumor angiogenesis by inhibition of peroxiredoxin 1 (prx1) |
| 06/16/2011 | WO2011071988A1 Methods and compositions using peroxiredoxin 1 (prx1) as an adjuvant |
| 06/16/2011 | WO2011071986A1 Enzymatic wound debriding compositions with enhanced enzymatic activity |
| 06/16/2011 | WO2011071968A2 Nanoparticle carrier systems based on human serum albumin for photodynamic therapy |
| 06/16/2011 | WO2011071957A1 Conjugates comprising an antibody surrogate scaffold with improved pharmacokinetic properties |
| 06/16/2011 | WO2011071927A2 Treatments for gastrointestinal disorders |
| 06/16/2011 | WO2011071926A1 Bche albumin fusions for the treatment of cocaine abuse |
| 06/16/2011 | WO2011071916A2 Sr-bi as a predictor of human female infertility and responsiveness to treatment |
| 06/16/2011 | WO2011071904A2 Inhibiting bacterial infection and biofilm formation |
| 06/16/2011 | WO2011071859A1 Method and composition to increase radiation-induced tumor therapeutic effects |
| 06/16/2011 | WO2011071739A1 Localized chemical lysis of ocular tissue |
| 06/16/2011 | WO2011071692A1 Modulating cellular electrophysiology |
| 06/16/2011 | WO2011071039A1 Identification of hla-dr4 epitope and use for treatment of arthritis |
| 06/16/2011 | WO2011070767A1 Prophylactic agent for atopic dermatitis |
| 06/16/2011 | WO2011070573A1 Antimicrobial water treatment membranes and production thereof |
| 06/16/2011 | WO2011070533A1 Peptides and their derivatives inhibiting extracellular release of hiv-1 tat protein and hiv-1 replication |
| 06/16/2011 | WO2011070364A1 Novel cyclic peptides |
| 06/16/2011 | WO2011070358A2 Product and method |
| 06/16/2011 | WO2011070032A1 Arenicin-3 for use in the treatment of urinary tract infections |
| 06/16/2011 | WO2011069527A1 Treatment scheme for idd and other automimmune diseases |
| 06/16/2011 | WO2011069280A1 Antimicrobial pexiganan analogue and preparation process thereof |
| 06/16/2011 | WO2011069227A1 Anti-microbial agent from paenibacillus sp. and methods and uses thereof |
| 06/16/2011 | WO2011069182A1 Compositions comprising zinc finger domains and uses therefor |
| 06/16/2011 | WO2011048503A3 Peptides that bind the alpha-fetoprotein (afp) receptor and uses thereof |
| 06/16/2011 | WO2011047868A3 Peptides used in the treatment and/or care of the skin, mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions |
| 06/16/2011 | WO2011045232A3 Neuropeptide-2 receptor (y-2r) agonists |
| 06/16/2011 | WO2011043830A3 Methods, agents and peptides for inducing an innate immune response in hiv vaccination |
| 06/16/2011 | WO2011036640A3 Meganuclease reagents of uses thereof for treating genetic diseases caused by frame shift/non sense mutations |
| 06/16/2011 | WO2011031476A3 Compositions and methods for treatment or prevention of post-operative organ or tissue inflammation |
| 06/16/2011 | WO2011029028A9 Targeted delivery using tissue-specific peptidomimetic ligands |
| 06/16/2011 | WO2011028344A3 Interleukin-1 receptor antagonist compositions and methods of making and using same |
| 06/16/2011 | WO2011028195A3 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| 06/16/2011 | WO2011024146A3 Adam12 inhibitors and their use against inflammation-induced fibrosis |
| 06/16/2011 | WO2011022462A3 Neural regeneration |
| 06/16/2011 | WO2011022357A3 Fast acting snare-cleaving enzymes |
| 06/16/2011 | WO2011022056A3 PEPTIDE MODULATORS OF THE δPKC INTERACTION WITH THE D SUBUNIT OF F1FO ATP SYNTHASE/ATPASE AND USES THEREOF |
| 06/16/2011 | WO2011017162A9 Methods for enhancing antigen-specific immune responses |
| 06/16/2011 | WO2011017107A3 Microbubble assisted viral delivery |
| 06/16/2011 | WO2011011847A3 Pharmaceutical composition for treating medical conditions and a method for treating alimentary disorders and related diseases |
| 06/16/2011 | WO2011011733A3 Factor replacement therapy |
| 06/16/2011 | WO2010149357A3 Methods of using corticotropin-releasing factor for the treatment of cancer |
| 06/16/2011 | WO2010132561A3 New human rotavirus strains and vaccines |
| 06/16/2011 | WO2010033912A3 Methods, systems, and compositions for calpain inhibition |
| 06/16/2011 | US20110144565 Combination of a tiliroside and a peptide |
| 06/16/2011 | US20110144309 Manipulation of Cytokine Levels Using CD83 Gene Products |
| 06/16/2011 | US20110144305 Gag binding protein |
| 06/16/2011 | US20110144186 Ssx-2 peptides presented by hla class ii molecules |
| 06/16/2011 | US20110144038 Human cd154-binding synthetic peptide and uses thereof |
| 06/16/2011 | US20110144037 Substrates and Inhibitors of Antiplasmin Cleaving Enzyme and Fibroblast Activation Protein and Methods of Use |
| 06/16/2011 | US20110144036 HIP/PAP Polypeptide Composition for Use in Liver Regeneration and for the Prevention of Liver Failure |
| 06/16/2011 | US20110144035 Methods and Compositions for Treating Conditions of the Eye |
| 06/16/2011 | US20110144034 Inhibition of tumor metastases using protein kinase c (pkc) inhibitors |
| 06/16/2011 | US20110144033 Proteasome Inhibitors and Methods of Using the Same |
| 06/16/2011 | US20110144032 Biological applications of steroid binding domains |
| 06/16/2011 | US20110144031 Pharmaceutical composition for inducing damages of endothelial cells and treating tumor and method for treating tumor by using the same |
| 06/16/2011 | US20110144030 Conjugate of hyaluronic acid for cosmetic treatment and preparation method |
| 06/16/2011 | US20110144029 Model Systems and Materials for the Study and Treatment of Neurodegenerative Diseases |
| 06/16/2011 | US20110144028 Modulating cellular electrophysiology |
| 06/16/2011 | US20110144027 Pharmaceutical compositions for promoting wound healing |
| 06/16/2011 | US20110144026 Method of Treating Low Blood Pressure |
| 06/16/2011 | US20110144025 Methods of Reducing Hemorrhage Due to Surgical Procedure |
| 06/16/2011 | US20110144024 Prevention and treatment of radiation injury |
| 06/16/2011 | US20110144023 Nano Cancer Barrier Device (NCBD) to Immobilize and Inhibit the Division of Metastic Cancer Stem Cells |
| 06/16/2011 | US20110144022 Anti-Angiogenic Peptide |
| 06/16/2011 | US20110144021 Therapeutic proteins from latex |
| 06/16/2011 | US20110144020 Treatment of infections and other disorders |
| 06/16/2011 | US20110144019 Method of treating chronic heart failure |